Hybrid micro-/nanoprotein platform provides endocrine-like and extracellular matrix-like cell delivery of growth factors

Carregant...
Miniatura
El pots comprar en digital a:
El pots comprar en paper a:

Projectes de recerca

Unitats organitzatives

Número de la revista

Títol de la revista

ISSN de la revista

Títol del volum

Cita com:

Col·laborador

Editor

Tribunal avaluador

Realitzat a/amb

Tipus de document

Article

Data publicació

Editor

Condicions d'accés

Accés obert

Llicència

Creative Commons
Aquesta obra està protegida pels drets de propietat intel·lectual i industrial corresponents. Llevat que s'hi indiqui el contrari, els seus continguts estan subjectes a la llicència de Creative Commons: Reconeixement 4.0 Internacional

Assignatures relacionades

Assignatures relacionades

Publicacions relacionades

Datasets relacionats

Datasets relacionats

Projecte CCD

Abstract

Protein materials are versatile tools in diverse biomedical fields. Among them, artificial secretory granules (SGs), mimicking those from the endocrine system, act as mechanically stable reservoirs for the sustained release of proteins as oligomeric functional nanoparticles. Only validated in oncology, the physicochemical properties of SGs, along with their combined drug-releasing and scaffolding abilities, make them suitable as smart topographies in regenerative medicine for the prolonged delivery of growth factors (GFs). Thus, considering the need for novel, safe, and cost-effective materials to present GFs, in this study, we aimed to biofabricate a protein platform combining both endocrine-like and extracellular matrix fibronectin-derived (ECM-FN) systems. This approach is based on the sustained delivery of a nanostructured histidine-tagged version of human fibroblast growth factor 2. The GF is presented onto polymeric surfaces, interacting with FN to spontaneously generate nanonetworks that absorb and present the GF in the solid state, to modulate mesenchymal stromal cell (MSC) behavior. The results show that SGs-based topographies trigger high rates of MSCs proliferation while preventing differentiation. While this could be useful in cell therapy manufacture demanding large numbers of unspecialized MSCs, it fully validates the hybrid platform as a convenient setup for the design of biologically active hybrid surfaces and in tissue engineering for the controlled manipulation of mammalian cell growth.

Descripció

Persones/entitats

Document relacionat

Versió de

Citació

Lopez-Laguna, H. [et al.]. Hybrid micro-/nanoprotein platform provides endocrine-like and extracellular matrix-like cell delivery of growth factors. «ACS applied materials and interfaces», 18 Juny 2024, vol. 16, núm. 26, p. 32930-32944.

Ajut

Forma part

Dipòsit legal

ISBN

ISSN

1944-8244

Referències